Lincoln Pharmaceuticals is currently trading at Rs. 198.60, up by 2.85 points or 1.46% from its previous closing of Rs. 195.75 on the BSE.
The scrip opened at Rs. 197.35 and has touched a high and low of Rs. 205.00 and Rs. 195.50 respectively. So far 64618 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 220.00 on 28-Jan-2020 and a 52 week low of Rs. 85.50 on 19-Mar-2020.
Last one week high and low of the scrip stood at Rs. 205.00 and Rs. 166.60 respectively. The current market cap of the company is Rs. 402.00 crore.
The promoters holding in the company stood at 32.36%, while Institutions and Non-Institutions held 0.43% and 67.21% respectively.
With a commitment towards ‘Healthcare For All’, Lincoln Pharmaceuticals has launched Chewable Vitamin C plus Zinc Tablet for the markets in India. The tablet is an evidence-based bio-active for natural immunity in combination of zinc that boosts antiviral activity and protection against COVID 19. Market size for Vitamin C and Zinc tablets is estimated at around Rs 150 crore in India and growing at 15% per annum.
Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |